KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) Research & Development (2016 - 2025)

Imax's Research & Development history spans 16 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Research & Development rose 26.17% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $5.8 million, up 13.97%, while the annual FY2025 figure was $5.8 million, 13.97% up from the prior year.
  • Research & Development for Q4 2025 was $1.5 million at Imax, down from $1.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.8 million in Q3 2023 and bottomed at -$265000.0 in Q3 2024.
  • The 5-year median for Research & Development is $1.5 million (2025), against an average of $1.7 million.
  • The largest annual shift saw Research & Development tumbled 109.56% in 2024 before it soared 667.92% in 2025.
  • A 5-year view of Research & Development shows it stood at $1.2 million in 2021, then surged by 30.85% to $1.6 million in 2022, then soared by 66.69% to $2.7 million in 2023, then tumbled by 57.75% to $1.2 million in 2024, then increased by 26.17% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's Research & Development are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).